It is a pharma private limited company based in Nashik, Maharashtra, India, established in 2011.
2011 | Nashik, Maharashtra, India | ActiveMedispin Pharmaceutical Private Limited, a active private limited company, was established on 14 November 2011 in Nashik, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24234MH2011PTC223904. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.30 M.
It upholds a compliant status. Its leadership includes Jaypalsingh Chandrasingh Jamadar (Director), Chetan Ekanath Firake (Director). Past directors included Changonda Sangonda Patil, Anita Prafulla Karpe, Chandan Rajgopal Soni. It holds ₹5.00 M open charges and ₹2.40 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop C 113, 1St Floor, Roongta Central Park Apartment, Dwarka, Nashik, Maharashtra, 422001.
U24234MH2011PTC223904
223904
14 November 2011
₹2.50 M
₹2.30 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medispin Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaypalsingh Chandrasingh Jamadar | Director | 14 Nov 2011 | Current |
| Chetan Ekanath Firake | Director | 14 Nov 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Oct 2023 | Past |
| Pramod Abcsdd | Director | 20 May 2019 | Past |
| Pramod Abcsdd | Director | 01 Sep 2023 | Past |
| Pramod Abcsdd | Director | 11 Oct 2023 | Past |
| Pramod Abcsdd | Director | 11 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medispin Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.42% decrease. The company also saw a substantial fall in profitability, with a 98.36% decrease in profit. The company's net worth moved up by a moderate rise of 0.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medispin Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹2,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2022 | Bank Of India | ₹5.00 M | Open |
| 18 Jan 2019 | Others | ₹2.40 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medispin Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medispin Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medispin Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medispin Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Medispin Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge registered on 18 Jan 2019 via Charge ID 100235303 with Others was fully satisfied on 29 Jul 2022. was completed.
A charge with Bank Of India amounted to Rs. 5.00 M with Charge ID 100617509 was registered on 11 Jul 2022. was recorded as a recent event.
A charge with Others of Rs. 2.40 M registered on 18 Jan 2019 with Charge ID 100235303 was modified on 23 Jul 2020. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 2.40 M with Charge ID 100235303 was registered on 18 Jan 2019. was documented.
The CIN of Medispin Pharmaceutical Private Limited is U24234MH2011PTC223904.
Medispin Pharmaceutical Private Limited is headquartered at Shop C 113, 1St Floor, Roongta Central Park Apartment, Dwarka, Nashik, Maharashtra, 422001.
Medispin Pharmaceutical Private Limited was incorporated on 14 November 2011.
The current directors of Medispin Pharmaceutical Private Limited are
The primary industry of Medispin Pharmaceutical Private Limited is Trade.
Medispin Pharmaceutical Private Limited is unlisted.
The authorized capital of Medispin Pharmaceutical Private Limited is ₹2.50 M, and the paid-up capital is ₹2.30 M.
The compliance status of Medispin Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX